Natural Compound from Olive Oil Inhibits S100A9 Amyloid Formation and Cytotoxicity: Implications for Preventing Alzheimer's Disease

被引:24
|
作者
Leri, Manuela [1 ,2 ]
Chaudhary, Himanshu [3 ]
Iashchishyn, Igor A. [3 ]
Pansieri, Jonathan [3 ]
Svedruzic, Zeljko M. [4 ]
Alcalde, Silvia Gomez [3 ]
Musteikyte, Greta [5 ]
Smirnovas, Vytautas [5 ]
Stefani, Massimo [1 ]
Bucciantini, Monica [1 ]
Morozova-Roche, Ludmilla A. [3 ]
机构
[1] Univ Florence, Dept Expt & Clin Biomed Sci Mario Serio, I-50134 Florence, Italy
[2] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, I-50139 Florence, Italy
[3] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden
[4] Univ Rijeka, Dept Biotechnol, HR-51000 Rijeka, Croatia
[5] Vilnius Univ, Life Sci Ctr, Inst Biotechnol, LT-10257 Vilnius, Lithuania
来源
ACS CHEMICAL NEUROSCIENCE | 2021年 / 12卷 / 11期
基金
英国医学研究理事会; 瑞典研究理事会;
关键词
amyloid; cytotoxicity; neurodegeneration; oleuropein aglycone; plant polyphenols; S100A9; CELLULAR PRION PROTEIN; COGNITIVE IMPAIRMENT; MEMBRANE DISRUPTION; IN-VITRO; EXPRESSION; MECHANISM; OLIGOMERS; NEUROINFLAMMATION; INFLAMMATION; BIOMARKER;
D O I
10.1021/acschemneuro.0c00828
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Polyphenolic compounds in the Mediterranean diet have received increasing attention due to their protective properties in amyloid neurodegenerative and many other diseases. Here, we have demonstrated for the first time that polyphenol oleuropein aglycone (OleA), which is the most abundant compound in olive oil, has multiple potencies for the inhibition of amyloid self-assembly of pro-inflammatory protein S100A9 and the mitigation of the damaging effect of its amyloids on neuroblastoma SH-SY5Y cells. OleA directly interacts with both native and fibrillar S100A9 as shown by intrinsic fluorescence and molecular dynamic simulation. OleA prevents S100A9 amyloid oligomerization as shown using amyloid oligomer-specific antibodies and cross-beta-sheet formation detected by circular dichroism. It decreases the length of amyloid fibrils measured by atomic force microscopy (AFM) as well as reduces the effective rate of amyloid growth and the overall amyloid load as derived from the kinetic analysis of amyloid formation. OleA disintegrates already preformed fibrils of S100A9, converting them into nonfibrillar and nontoxic aggregates as revealed by amyloid thioflavin-T dye binding, AFM, and cytotoxicity assays. At the cellular level, OleA targets S100A9 amyloids already at the membranes as shown by immunofluorescence and fluorescence resonance energy transfer, significantly reducing the amyloid accumulation in GM1 ganglioside containing membrane rafts. OleA increases overall cell viability when neuroblastoma cells are subjected to the amyloid load and alleviates amyloid-induced intracellular rise of reactive oxidative species and free Ca2+. Since S100A9 is both a pro-inflammatory and amyloidogenic protein, OleA may effectively mitigate the pathological consequences of the S100A9-dependent amyloid-neuroinflammatory cascade as well as provide protection from neurodegeneration, if used within the Mediterranean diet as a potential preventive measure.
引用
收藏
页码:1905 / 1918
页数:14
相关论文
共 50 条
  • [1] Formation of Calprotectin Inhibits Amyloid Aggregation of S100A8 and S100A9 Proteins
    Baronaite, Ieva
    Sulskis, Darius
    Kopustas, Aurimas
    Tutkus, Marijonas
    Smirnovas, Vytautas
    ACS CHEMICAL NEUROSCIENCE, 2024, 15 (09): : 1915 - 1925
  • [2] The Stabilization of S100A9 Structure by Calcium Inhibits the Formation of Amyloid Fibrils
    Sanders, Ella
    Csondor, Rebecca
    Sulskis, Darius
    Baronaite, Ieva
    Smirnovas, Vytautas
    Maheswaran, Luckshi
    Horrocks, Jack
    Munro, Rory
    Georgiadou, Christina
    Horvath, Istvan
    Morozova-Roche, Ludmilla A.
    Williamson, Philip T. F.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)
  • [3] The Role of S100a9 in the Pathogenesis of Alzheimer's Disease: The Therapeutic Effects of S100a9 Knockdown or Knockout
    Chang, Keun-A
    Kim, Hee Jin
    Suh, Yoo-Hun
    NEURODEGENERATIVE DISEASES, 2012, 10 (1-4) : 27 - 29
  • [4] Inflammatory S100A9 and S100A12 proteins in Alzheimer's disease
    Shepherd, C. E.
    Goyette, J.
    Utter, V.
    Rahimi, F.
    Yang, Z.
    Geczy, C. L.
    Halliday, G. M.
    NEUROBIOLOGY OF AGING, 2006, 27 (11) : 1554 - 1563
  • [5] The role of pro-inflammatory S100A9 in Alzheimer's disease amyloid-neuroinflammatory cascade
    Wang, Chao
    Klechikov, Alexey G.
    Gharibyan, Anna L.
    Warmlander, Sebastian K. T. S.
    Jarvet, Juri
    Zhao, Lina
    Jia, Xueen
    Shankar, S. K.
    Olofsson, Anders
    Brannstrom, Thomas
    Mu, Yuguang
    Graslund, Astrid
    Morozova-Roche, Ludmilla A.
    ACTA NEUROPATHOLOGICA, 2014, 127 (04) : 507 - 522
  • [6] The role of pro-inflammatory S100A9 in Alzheimer’s disease amyloid-neuroinflammatory cascade
    Chao Wang
    Alexey G. Klechikov
    Anna L. Gharibyan
    Sebastian K. T. S. Wärmländer
    Jüri Jarvet
    Lina Zhao
    Xueen Jia
    S. K. Shankar
    Anders Olofsson
    Thomas Brännström
    Yuguang Mu
    Astrid Gräslund
    Ludmilla A. Morozova-Roche
    Acta Neuropathologica, 2014, 127 : 507 - 522
  • [7] Erratum to: The role of pro-inflammatory S100A9 in Alzheimer’s disease amyloid-neuroinflammatory cascade
    Chao Wang
    Alexey G. Klechikov
    Anna L. Gharibyan
    Sebastian K. T. S. Wärmländer
    Jüri Jarvet
    Lina Zhao
    Xueen Jia
    Vinod K. Narayana
    S. K. Shankar
    Anders Olofsson
    Thomas Brännström
    Yuguang Mu
    Astrid Gräslund
    Ludmilla A. Morozova-Roche
    Acta Neuropathologica, 2014, 128 : 461 - 461
  • [8] Corticosteroid treatment of Alzheimer's disease: is S100A9/Mrp14 a key target?
    Kametani, Fuyuki
    NEUROBIOLOGY OF AGING, 2014, 35 (04) : E11 - E12
  • [9] S100A9 inhibits and redirects prion protein 89-230 fragment amyloid aggregation
    Ziaunys, Mantas
    Sulskis, Darius
    Mikalauskaite, Kamile
    Sakalauskas, Andrius
    Snieckute, Ruta
    Smirnovas, Vytautas
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2024, 758
  • [10] The role of pro-inflammatory S100A9 in Alzheimer's disease amyloid-neuroinflammatory cascade (vol 127, pg 507, 2014)
    Wang, Chao
    Klechikov, Alexey G.
    Gharibyan, Anna L.
    Warmlander, Sebastian K. T. S.
    Jarvet, Juri
    Zhao, Lina
    Jia, Xueen
    Narayana, Vinod K.
    Shankar, S. K.
    Olofsson, Anders
    Brannstrom, Thomas
    Mu, Yuguang
    Graslund, Astrid
    Morozova-Roche, Ludmilla A.
    ACTA NEUROPATHOLOGICA, 2014, 128 (03) : 461 - 461